GT Biopharma Inc. (GTBP) PT Lowered to $5 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts GTBP Hot Sheet
Price: $0.30 -3.23%
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
H.C. Wainwright analyst Robert Burns lowered the price target on GT Biopharma Inc. (NASDAQ: GTBP) to $5.00 (from $25.00) while maintaining a Buy rating.
You May Also Be Interested In
- Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
- Suzuken Co Ltd (9987:JP) PT Lowered to JPY5,570 at Nomura/Instinet
- Nomura/Instinet Upgrades Seiko Group Corp (8050:JP) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
